Three-Dimensional Augmented Reality Visualization Informs Locoregional Therapy in a Translational Model of Hepatocellular Carcinoma.
Three-Dimensional Augmented Reality Visualization Informs Locoregional Therapy in a Translational Model of Hepatocellular Carcinoma.
复制标题
DOI:
10.1016/j.jvir.2020.01.028
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Gade TP
中科院分区:
文献类型:
--
作者:
Park BJ;Perkons NR;Profka E;Johnson O;Morley C;Appel S;Nadolski GJ;Hunt SJ;Gade TP
To evaluate the utility of visualizing pre-procedure MRI in three-dimensional (3D) space using augmented reality (AR) prior to transarterial embolization (TAE) of hepatocellular carcinoma (HCC) in a preclinical model. A prospective study with a total of 28 rats with diethylnitrosamine (DEN)-induced HCC and tumors greater than 5 mm treated with TAE were included. In 12 rats, 3D AR visualization of the pre-procedure MRI was performed prior to TAE. Procedural metrics including catheterization time and radiation exposure were compared to a prospective cohort of 16 rats in whom TAE was performed without AR. An additional cohort of 15 retrospective cases were identified and combined with the prospective control cohort (n=31) to improve statistical power. A reduction in fluoroscopy time was observed after AR when compared prospectively from 11.7 to 7.4 min (37%; p=0.12), which did not reach statistical significance; however, when compared to combined prospective and retrospective controls, the reduction in fluoroscopy time was significant from 14.1 to 7.4 min (48%; p=0.01). A reduction in total catheterization time was also observed after AR when compared prospectively from 42.7 to 31.0 min (27%; p=0.11), which did not reach statistical significance. No significant differences were seen in dose area product (DAP) or air kerma (AK) prospectively. 3D AR visualization of pre-procedural imaging may aid in the reduction of procedural metrics in a preclinical model of TACE. These data support the need for further studies to evaluate the potential of AR on endovascular oncologic interventions.
登录
查看更多内容
DOI:
10.1016/j.jvir.2017.03.037
发表时间:
2017-07
期刊:
Journal of vascular and interventional radiology : JVIR
影响因子:
--
作者:
Kiefer RM;Hunt SJ;Pulido S;Pickup S;Furth EE;Soulen MC;Nadolski GJ;Gade TP
通讯作者:
Gade TP
DOI:
10.1016/j.jvir.2018.02.018
发表时间:
2018-07-01
影响因子:
2.9
作者:
Mohammed, Mohammed Ahmed Abdelrazek;Khalaf, Mohamed H.;Kothary, Nishita
通讯作者:
Kothary, Nishita
影响因子:
5.5
作者:
Mitsouras, Dimitris;Liacouras, Peter;Rybicki, Frank J.
通讯作者:
Rybicki, Frank J.
影响因子:
3.9
作者:
Tack P;Victor J;Gemmel P;Annemans L
通讯作者:
Annemans L
影响因子:
2
作者:
Karmonik, Christof;Elias, Saba N.;Britz, Gavin W.
通讯作者:
Britz, Gavin W.